<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of <z:hpo ids='HP_0011010'>chronic</z:hpo> administration of variable low doses of Aspirin was studied on platelet adhesiveness, platelet count, <z:mp ids='MP_0001914'>bleeding</z:mp> time and clotting time to find out as to how low the dose of aspirin needs to be in order to have an effective antiplatelet effect in patients who require such therapy </plain></SENT>
<SENT sid="1" pm="."><plain>A statistically significant reduction in the platelet adhesiveness was observed in <z:hpo ids='HP_0000001'>all</z:hpo> the groups, but the best effect was exhibited by 50 mgm of aspirin dose </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0001914'>Bleeding</z:mp> time was also increased in <z:hpo ids='HP_0000001'>all</z:hpo> the groups but statistically significant difference was observed with 50, 75 and 100 mgm doses </plain></SENT>
<SENT sid="3" pm="."><plain>There was no change in platelet count and clotting time </plain></SENT>
</text></document>